Free Newsletter
Obama, McCain united against drug costs
Despite a lack of socialized medicine in the United States, the U.S. government pays a hefty 45 percent of the total expenditure of healthcare, and drugs represent a large percentage of the costs. Both Obama and McCain are prioritizing big pharma in their campaign goals to cut costs, which might be part of the reason for industry stock drops. Report
Comments
Post new comment
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges





Click here to get the FiercePharma email newsletter for FREE!
Be the first to comment